15 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
35
First-in-Class Selective Inhibitors of the Lysine Acetyltransferase KAT8.

Sapienza University of Rome
35
Structure-activity relationship and antitumor activity of 1,4-pyrazine-containing inhibitors of histone acetyltransferases P300/CBP.

Baylor College of Medicine
30
Histone acetyltransferase inhibitors: An overview in synthesis, structure-activity relationship and molecular mechanism.

Sichuan University
181
Discovery of Acylsulfonohydrazide-Derived Inhibitors of the Lysine Acetyltransferase, KAT6A, as Potent Senescence-Inducing Anti-Cancer Agents.

Monash University (Parkville Campus)
87
Discovery of Benzoylsulfonohydrazides as Potent Inhibitors of the Histone Acetyltransferase KAT6A.

Cancer Therapeutics Crc
40
Discovery, Structure-Activity Relationship, and Biological Activity of Histone-Competitive Inhibitors of Histone Acetyltransferases P300/CBP.

Avera Institute For Human Genetics
576
Cyclopropyl Fused Thiazin-2-Amine Compounds as Beta-Secretase Inhibitors and Methods of Use

Amgen
31
Substituted heterocycles as aldehyde dehydrogenase inhibitors

Kayothera
60
ERAP INHIBITORS

Universite De Lille
303
Isoquinolin-3-yl carboxamides and preparation and use thereof

Biosplice Therapeutics
82
Mu opioid receptor modulators

University of California
4
2,3-dihydrofuro[2,3-b]pyridine compounds

Eli Lilly
49
Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)

Prelude Therapeutics
325
Benzenesulfonamide compounds and their use as therapeutic agents

Xenon Pharmaceuticals
161
Methylamine derivatives as lysysl oxidase inhibitors for the treatment of cancer

The Institute of Cancer Research: Royal Cancer Hospital